Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 19, 2021 10:02am
158 Views
Post# 32325414

RE:RE:Predictions?

RE:RE:Predictions?"Keeping that in mind, it is not a bad thing if they release Aristotle in March. until then they are banking money daily. "

They will continue to bank money.  Being able to commercialize Aristotle does not stop the CoVid revenue in fact I can see them running both revenue streams for the back half of 2021 and into 2022.

Imagine they can achieve 3000 daily tests of Covid and start Aristotle while being able to maintain the steady CoVid revenues. Millipns a month in revenue while rolling out your game changing technology.   Ichor will promote Aristotle in Canada and Mercer in the US.  

No way this market cap stays at $60 million.   I see other CoVid plays like cbdt, sona and thrm with market caps 2-3 times ours and they dont have Aristotle.  We should be easily double the share price on CoVid alone and Aristotle taking us well over $3 and closer to Clarus with a $4-5 share price.

So the next 2 months are going to be fun.

 


Bully88 wrote: It is very hard to make predictions as none of us have a crystal ball,

How ever, given the outline for covid testing to ramp up going into 2021, the multiple hires doubling their staff, the extreme numbers of tests being done across north america,

I feel as a very conservative 1200-1500 tests a day is a good base to have expectations for.

Some may say that is too high, as in q3 when we looked at their revenue, did some simple math, we deemed them to be doing 250-300 tests a day, then for q4 all of the lab staff hirings makes me believe we hit our lab capacity which we then expanded and are continuing to grow in 2021.

As for Aristotle. It is again, very hard to predict any release date other then Q1 2020.

That gives us until end of march. Anything after that is a disapointment, anything earlier than that is a bonus, and for me would be quite surprising as they have been so bang on with their timelines and milestones in their prospectus and should easily meet targets. 

Keeping that in mind, it is not a bad thing if they release Aristotle in March. until then they are banking money daily. 

ive included my  Revenue Spreadsheet below as it has been too long since it has been posted and i missed it lol, and to remind everyone that every day they are printing money.

Every month, every day extra covid revenue is amazing for this company. An extra million or 2 can make a huge difference.

Its more Money in our pockets to market Aristotle and build our reputation as a powerhouse lab.

The only thing i believe is an extremly important catalyst for them to release Aristotle early is to gaurantee they are first to market with this technology. that will add an extreme value to their name, and i truly hope they dont miss that chance.

Predicting when SZLS will release news on any of the things i have mentioned is another topic... as much as id like to hear more, i kinda like their brief, heres our prospectus, weve hit on target and will continue to do so now f off while we get back to saving lives and make us all a sh*t ton of money attitude. Does it leave us retail investors a little nervous and at times frustrated? absolutely. 

But it has attracted some very serious players, and institutial investors, to buy in large.

This company is extremely undervalued in my opinion. 
With like 60 million shares outstanding and a market cap of 55mil, and making millions every quarter, and a game changing tech about to comercialize. 

Im all in. currently up 50% 

I foresee in the very near future i will be up in the  multiple 100's of % and so will many others, even buying in at these rediculous low price ranges of 90c.

Something happened the start of q1 2021 and it has everyone here with the same feeling of excitement, as we all know its any day now we are going to wake up to MASSIVE news, and the train will leave the station and bring us to Cashmoneysville.

Cheers all,

Bully



Daily Tests Completed Revenue Per Test Daily Revenue Monthly Revenue Quarterly Revenue Yearly Revenue
100  $    75.00  $     7,500.00  $    225,000.00  $      675,000.00  $   2,700,000.00
200  $    75.00  $   15,000.00  $    450,000.00  $   1,350,000.00  $   5,400,000.00
300  $    75.00  $   22,500.00  $    675,000.00  $   2,025,000.00  $   8,100,000.00
400  $    75.00  $   30,000.00  $    900,000.00  $   2,700,000.00  $ 10,800,000.00
500  $    75.00  $   37,500.00  $ 1,125,000.00  $   3,375,000.00  $ 13,500,000.00
600  $    75.00  $   45,000.00  $ 1,350,000.00  $   4,050,000.00  $ 16,200,000.00
700  $    75.00  $   52,500.00  $ 1,575,000.00  $   4,725,000.00  $ 18,900,000.00
800  $    75.00  $   60,000.00  $ 1,800,000.00  $   5,400,000.00  $ 21,600,000.00
900  $    75.00  $   67,500.00  $ 2,025,000.00  $   6,075,000.00  $ 24,300,000.00
1000  $    75.00  $   75,000.00  $ 2,250,000.00  $   6,750,000.00  $ 27,000,000.00
1100  $    75.00  $   82,500.00  $ 2,475,000.00  $   7,425,000.00  $ 29,700,000.00
1200  $    75.00  $   90,000.00  $ 2,700,000.00  $   8,100,000.00  $ 32,400,000.00
1300  $    75.00  $   97,500.00  $ 2,925,000.00  $   8,775,000.00  $ 35,100,000.00
1400  $    75.00  $ 105,000.00  $ 3,150,000.00  $   9,450,000.00  $ 37,800,000.00
1500  $    75.00  $ 112,500.00  $ 3,375,000.00  $10,125,000.00  $ 40,500,000.00
1600  $    75.00  $ 120,000.00  $ 3,600,000.00  $10,800,000.00  $ 43,200,000.00
1700  $    75.00  $ 127,500.00  $ 3,825,000.00  $11,475,000.00  $ 45,900,000.00
1800  $    75.00  $ 135,000.00  $ 4,050,000.00  $12,150,000.00  $ 48,600,000.00
1900  $    75.00  $ 142,500.00  $ 4,275,000.00  $12,825,000.00  $ 51,300,000.00
2000  $    75.00  $ 150,000.00  $ 4,500,000.00  $13,500,000.00  $ 54,000,000.00
2100  $    75.00  $ 157,500.00  $ 4,725,000.00  $14,175,000.00  $ 56,700,000.00
2200  $    75.00  $ 165,000.00  $ 4,950,000.00  $14,850,000.00  $ 59,400,000.00
2300  $    75.00  $ 172,500.00  $ 5,175,000.00  $15,525,000.00  $ 62,100,000.00
2400  $    75.00  $ 180,000.00  $ 5,400,000.00  $16,200,000.00  $ 64,800,000.00
2500  $    75.00  $ 187,500.00  $ 5,625,000.00  $16,875,000.00  $ 67,500,000.00
2600  $    75.00  $ 195,000.00  $ 5,850,000.00  $17,550,000.00  $ 70,200,000.00
2700  $    75.00  $ 202,500.00  $ 6,075,000.00  $18,225,000.00  $ 72,900,000.00
2800  $    75.00  $ 210,000.00  $ 6,300,000.00  $18,900,000.00  $ 75,600,000.00
2900  $    75.00  $ 217,500.00  $ 6,525,000.00  $19,575,000.00  $ 78,300,000.00
3000  $    75.00  $ 225,000.00  $ 6,750,000.00  $20,250,000.00  $ 81,000,000.00



<< Previous
Bullboard Posts
Next >>